Debevoise Advises TPG and WCAS in the Sale of Kindred at Home to Humana, Valuing KAH at $8.1 Billion

28 April 2021

Debevoise & Plimpton LLP is advising TPG Capital (TPG) and Welsh, Carson, Anderson & Stowe in the sale of Kindred at Home (KAH) to Humana Inc. (NYSE: HUM), a transaction that values KAH at $8.1 billion. KAH will adopt Humana’s new payer-agnostic healthcare services brand and transition to CenterWell Home Health. Expected to close in the third quarter of 2021, this acquisition reflects Humana’s continued commitment to investing in home-based clinical solutions that drive improved patient outcomes, increased satisfaction for patients and providers and value for health plan partners. For more information, please see the company’s press release.

Kindred at Home is the largest home health and hospice provider in the United States. Humana is an American health insurance company committed to helping millions of medical and specialty members achieve their best health.

The Debevoise team is led by M&A partner Andrew Bab and includes benefits partner Lawrence Cagney and tax partner Gary Friedman and associate Samuel Krawiecz.